1. Identification and Validation of Immune Cells and Hub Genes in Gastric Cancer Microenvironment
   Huan Wang et al, 2022, Disease Markers CrossRef
2. Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma
   X. Gan et al, 2021, Journal of Endocrinological Investigation CrossRef
3. Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
   Margarita Pustovalova et al, 2023, International Journal of Molecular Sciences CrossRef
4. Screening differentially expressed proteins to distinguish thymoma (B1 and B3) from thymic cysts based on tandem mass tag (TMT) technology
   Jingwei Shi et al, 2024, Journal of Cardiothoracic Surgery CrossRef
5. F10 Gene Expression and Ethnic Disparities Present in Papillary Thyroid Carcinoma
   Tyrel Porter et al, 2024, Journal of Personalized Medicine CrossRef
6. Identification of a 3-Gene Prognostic Index for Papillary Thyroid Carcinoma
   Lin-Kun Zhong et al, 2022, Frontiers in Molecular Biosciences CrossRef
7. Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment
   Li Yang et al, 2023, Toxics CrossRef
8. Identifying Novel Psoriatic Disease Drug Targets Using a Genetics-Based Priority Index Pipeline
   Audrey Bui et al, 2021, Journal of Psoriasis and Psoriatic Arthritis CrossRef
9. Beyond the Usual Suspects: Examining the Role of Understudied Histone Variants in Breast Cancer
   Hejer Dhahri et al, 2024, International Journal of Molecular Sciences CrossRef
10. PCPE-2 (procollagen C-proteinase enhancer-2): The non-identical twin of PCPE-1
    Manon Napoli et al, 2024, Matrix Biology CrossRef
11. Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model
    Lin Xiang et al, 2024, Medicine CrossRef